MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    CANVAS and Sleep Disorder: a Prospective Cross-Sectional Study

    A. Funcis, G. Dalla Zanna, S. Rossi, F. Madia, G. Silvestri, V. Brunetti (Rome, Italy)

    Objective: Aim in this study is to characterize, for the first time, sleep and its disorders in patients with CANVAS genetically confirmed. Background: Cerebellar ataxia,…
  • 2024 International Congress

    Gait and turning during daily life across the spectrum of normal, prodromal, early and moderate Parkinson’s disease

    M. Mancini, V. Shah, P. Burgos, P. Carlson-Kuhta, L. Talman, M. Lim, J. Quinn, F. Horak (Portland, USA)

    Objective: To compare gait and turning quality during daily life in older adults, people with Rapid Eye Movement (REM) sleep behavior disorder (RBD) and people…
  • 2024 International Congress

    4-Aminopyridine improves downbeat nystagmus in SCA27b: A case report

    S. Coulette, M. Philibert, JM. Trocello, B. Gaymard, C. Desjardins (Paris, France)

    Objective: To assess objective clinical improvement in video-oculography in a patient with SCA27b on 4-aminopyridine (4-AP) treatment. Background: Spinocerebellar ataxia 27b (SCA27b; MIM 620174) is…
  • 2024 International Congress

    Pressure Sensor Insole Gait Assessment for Parkinson’s Disease patients: A longitudinal study.

    G. Karamanis, V. Skaramagkas, I. Boura, C. Chatzaki, E. Chroni, D. Fotiadis, C. Spanaki, M. Tsiknakis, Z. Kefalopoulou (Patras, Greece)

    Objective: To evaluate a computational analysis of gait, based on pressure sensors insoles data, by correlating it with clinical assessments of motor symptoms in Parkinson's…
  • 2024 International Congress

    Dentate Deep Brain Stimulation for Cerebellar Ataxia: Long Term Outcomes

    C. França, J. Diniz, I. Paraguay, D. de Andrade, V. Silva, R. Galhardoni, M. Teixeira, E. Barbosa, R. Cury (São Paulo, Brazil)

    Objective: To evaluate long-term results of Deep Brain Stimulation (DBS) targeting the dentate nucleus (DN) in patients with cerebellar ataxia Background: Cerebellar ataxia remains a…
  • 2024 International Congress

    Speech Processing System for Parkinson’s Disease Using Mixed Reality

    M. Wójcik-Pędziwiatr, M. Dudek, W. Skibicka, M. Rudzińska-Bar, M. Danioł, P. Jemioło, J. Stępień, D. Hemmerling (Cracow, Poland)

    Objective: Our initiative aims to develop an integrated AR/MR platform for collecting diagnostic data and monitoring patients with neurodegenerative diseases using digital markers from registered…
  • 2024 International Congress

    Candidate biomarkers of EV-microRNA in detecting REM sleep behavior disorder and Parkinson’s disease

    Y. Li, J. Liu, L. Wu (shanghai, China)

    Objective: Accessible and reliable biomarkers for early diagnosis of PD and iRBD are urgently needed to identify candidate therapeutic targets and to monitor disease progression…
  • 2024 International Congress

    White Matter Tractography in Spinocerebellar Ataxia type 1 and 2 in comparison with Healthy Controls

    P. Pankaj, A. Srivastava, M. Kumar, S. Kumaran, A. Garg, R. Agarwal, A. Nehra (New Delhi, India)

    Objective: To assess and quantify microstructural white matter atrophy in brain of spinocerebellar ataxia (SCA) types SCA1 and SCA2 patients in comparison with healthy subjects.…
  • 2024 International Congress

    Pulmonary Dysfunction in Friedreich’s Ataxia (FRDA)

    T. Zesiewicz, T. Vu, A. Patel, T. Mcdonald, Y. Huang, Y. Zhao, L. Campbell, L. Evans, D. Mohan, C. Gooch, K. Calero (Tampa, USA)

    Objective: We sought to characterize pulmonary function in FRDA and identify disease variables that may contribute to dysfunction. Background: FRDA is a neurodegenerative disease that causes…
  • 2024 International Congress

    Alterations in the Daily Living Gait and Mobility during the Day and Night among Individuals with Cerebellar Ataxia, SCA3: An Exploratory Study

    P. Ponger, A. Solomon, M. Brozgol, E. Gazit, J. Hausdorff (Tel Aviv, Israel)

    Objective: In this pilot study, we aimed to examine step counts and daily living physical activity, confirm findings regarding gait variability, explore changes in nighttime…
  • « Previous Page
  • 1
  • …
  • 159
  • 160
  • 161
  • 162
  • 163
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Home-based transcranial static magnetic field stimulation of the motor cortex for treating levodopa-induced dyskinesias in Parkinson’s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley